Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRT-448 in Healthy Adult Subjects
NCT07745751Phase 1Not yet recruiting
- Sponsor
- Trotana Therapeutics
- Start
- Aug 2026
- Primary completion
- Apr 2027
01
Overview
Phase 1, randomised, double-blind trial in Inflammatory Disorders comparing TRT-448 with Placebo (2 arms). Primary endpoint: Safety and tolerability. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
TRT-448
03
Conditions
Inflammatory Disorders
Beyond the preview
Go deeper on NCT07745751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07745751.